Skip to main content

MoneyWorks4Me

Laurus Labs informs about press release

27 Jul 2022 Evaluate

Laurus Labs has informed that it enclosed the Press Release on the financial results for the quarter ended June 30, 2022 titled 'Laurus Labs reports strong momentum in Revenues and Profits for Q1 FY23'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..